Castle Biosciences, Inc. (CSTL) stock is soaring 5.03% during Wednesday's trading session, showcasing significant momentum in the biotechnology sector. The stock's upward movement has caught the attention of investors and market analysts alike.

The surge in Castle Biosciences' stock price coincides with BTIG reiterating its Buy rating on the company. This vote of confidence from a respected financial services firm appears to have bolstered investor sentiment, potentially contributing to the stock's impressive intraday gains.

Analyst ratings often play a crucial role in shaping market perceptions and influencing stock prices, especially for smaller biotechnology companies like Castle Biosciences. While the maintenance of a Buy rating doesn't provide new information, it reinforces the positive outlook on the company's prospects, which may be encouraging more investors to take positions in the stock.